Could there one day be a biopsy that is non-invasive? Startup OncoHost is advancing a non-invasive method for detecting and monitoring cancer through the analysis of blood, urine, or cerebrospinal fluid: ats.org/ats-news/can-l…

@BioProcessIntll has published an insightful article featuring our CEO, Dr. Ofer Sharon, on the challenges of estimating #ICI suitability in #cancertreatment. 🧬 Learn about our innovative approach and how it’s shaping the future of #precisiononcology: tinyurl.com/m5x6r7u4

We're proud to announce that 3 of our research abstracts have been selected for presentation at #WCLC2024, diving deep into the power of #proteomics to predict outcomes & manage toxicities in #lungcancer patients. Read more: tinyurl.com/35muvmec #LCSM #PrecisionOncology

We are proud to participate in this #BestofASCO Advent Health event! Our Director of Scientific Affairs, Anna Manasherov, will be there to discuss how our latest data can be applied in clinical settings, advances in treatment strategies, and the role of #precisionmedicine.

This #WorldCancerSupportMonth let's unite to offer unwavering support to the millions battling or are being affected by cancer. To get involved in local support initiatives, @lungevity has a great calendar of events to participate in: bit.ly/3LULMxC #CancerSupport

PROphetNSCLC™️ integrates #proteomics and #machinelearning with PD-L1 expression, providing a more precise method for identifying patients likely to obtain clinical benefit from PD-1/PD-L1 inhibitor therapies. To learn more, contact us today: oncohost.com/contact #NSCLC

Thanks to EPM Magazine for sharing our #WCLC2024 abstract news! If you're attending WCLC and want to meet, come by our booth #2500, or attend one of our exciting presentations. Read more: tinyurl.com/3rp4t7uy #LCSM #precisiononcology #conference

A new study reveals that combining vaping with smoking increases #lungcancer risk by 4 times compared to smoking alone. Vaping is not a safe alternative to smoking, and using both drastically escalates cancer risk. bit.ly/4dupjU3 #StopSmoking #NSCLC #LCSM

For #WorldCancerSupportMonth, we salute oncologists! From AI to innovative tech, you're revolutionizing cancer care. Your dedication to cutting-edge treatments brings hope to countless patients. To all #oncologists: Your pursuit of better outcomes changes lives. Thank you!

PD-L1 expression: Does it match your patient with the best treatment? PROphetNSCLC™️ challenges conventional #biomarkers, using #AI to analyze proteomic data. Can it improve #immunotherapy outcomes for your #NSCLC patients? Learn more here: bit.ly/3MktuGD #LCSM

Meet Nava, our Head of Scientific Affairs! Nava is a beacon of expertise and mentorship, guiding our team with her profound knowledge of #precisiononcology When she isn't helping us change the future of #CancerCare, she enjoys multiple sports!💪 #EmployeeSpotlight #MeetTheTeam

Our collab with the prestigious Dana-Farber aims to identify critical #biomarkers and develop new proteomic profiling tech to revolutionize treatment for #RCC patients. This is a hint at something even bigger coming your way at #ESMO2024—stay tuned! 👀 tinyurl.com/4skp7p8c

Join OncoHost at the World Conference on Lung Cancer (#WCLC2024)! We're thrilled to present our latest research with one mini-oral and two poster presentations. Visit booth #2500 to discover how we optimize #immunotherapy outcomes with a single blood draw. Let's connect!

Today, OncoHost Israel will pause operations to stand in solidarity with the hostages and their families. This is a time for reflection, unity, and strength. Our commitment to improving patient care remains steadfast during these challenging moments. #BringThemHomeNow

Happy Labor Day to our US-based team and partners! We hope your weekend has been filled with celebration, relaxation, and a shared sense of gratitude 🌞 #laborday #LDW #labordayweekend #happylaborday

🚀 Our team attending #ESMO2024 in Barcelona! Join leading experts as they share the latest in #oncology, focusing on personalized #cancertreatment. Stay tuned for exciting updates—we've got great news coming soon! To connect, email us at [email protected]. See you there!

The FDA has approved a new combination therapy for first-line treatment of adults with locally advanced or #metastatic non–small cell lung cancer with #EGFR mutations. This new option brings renewed hope to those facing this challenging diagnosis. tinyurl.com/mpjdbekw #LCSM

Dr. Itamar Sela will delve into mechanisms of #immunotherapy resistance in #mNSCLC, offering valuable insights into the biological processes underlying resistance to immunotherapy during a poster presentation at #WCLC2024 on September 8. Find him at Poster #2495 or booth #2500!

We're excited to be at the World Conference on Lung Cancer #WCLC2024 this week! Yesterday, our team had a great poster presentation on our latest research findings and our booth has been busy as well. Are you attending WCLC? Stop by our booth #2500 to meet our team!

Prof. Jarushka Naidoo is presenting research on using plasma #proteomics to predict immunotherapy & chemotherapy toxicity in #NSCLC patients at #WCLC2024 on Tuesday, Sept 10th at 11:15am PDT. Don't miss this presentation in Room 30DE on leveraging proteomics as #biomarkers.